IHC biomarker

Articles

• TNXB
  22 September 2003

  Tenascin X

• GCM2
  12 March 2009

  glial cells missing (Drosophila) homolog b, hGCMb, MIM.603716

• KAI1/CD82
  8 November 2005, by JA

  ST6, CD82

• KRT19
  14 December 2007

  cytokertain-19

• CNN1
  25 June 2011

  calponin-1, calponin

• EMA
  30 April 2008, by JA

  epithelial membrane antigen

• IMP3/L523S
  22 January 2010

  Pathology
  IMP3 antibody is a highly specific marker for malignant lesions.
  Differentiating reactive mesothelial cells from metastatic carcinoma and malignant mesothelioma is critical in effusion cytology.
  Numerous immunohistochemical/cytochemical reports use various antibodies in effusion samples, and most antibodies differentiate metastatic adenocarcinoma from malignant mesothelioma, but no antibodies help distinguish malignant mesothelioma from reactive mesothelial cells.
  A mouse (...)

0 | 10 | 20 | 30